Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NCT07565350Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of hydrogen peroxide gel in refractory viral warts (2 arms), sponsored by First Hospital of China Medical University. Primary endpoints: Complete clearance rate of warts at 6 months, Recurrence rate of warts at 12 months and 3 more. Started Oct 2025; status: recruiting.
02
Drugs
hydrogen peroxide gel
03
Conditions
refractory viral warts
Beyond the preview
Go deeper on NCT07565350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07565350.